ES474575A1 - Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos - Google Patents

Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos

Info

Publication number
ES474575A1
ES474575A1 ES474575A ES474575A ES474575A1 ES 474575 A1 ES474575 A1 ES 474575A1 ES 474575 A ES474575 A ES 474575A ES 474575 A ES474575 A ES 474575A ES 474575 A1 ES474575 A1 ES 474575A1
Authority
ES
Spain
Prior art keywords
bibenzyls
aminoalkoxy
omega
substances
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474575A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP52120710A external-priority patent/JPS6021578B2/ja
Priority claimed from JP8583378A external-priority patent/JPS5513222A/ja
Priority claimed from JP9404478A external-priority patent/JPS5520740A/ja
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Publication of ES474575A1 publication Critical patent/ES474575A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
    • Y10T428/258—Alkali metal or alkaline earth metal or compound thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La invención se refiere a la producción de (omega-aminoalcoxi) bibencilos que son farmacológicamente activos como inhibidores de la agregación de plaquetas. Más particularmente, esta invención se refiere a la preparación de 2-(omega- aminoalcoxi)bibencilos y de composiciones farmacéuticas que los contienen, eficaces para la inhibición de la agregación de plaquetas.
ES474575A 1977-10-07 1978-10-06 Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos Expired ES474575A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP52120710A JPS6021578B2 (ja) 1977-10-07 1977-10-07 （オメガ−アミノアルコキシ）ビベンジル類
JP8583378A JPS5513222A (en) 1978-07-14 1978-07-14 Aminoalkoxybibenzyl and its acid addition salt
JP9404478A JPS5520740A (en) 1978-08-01 1978-08-01 Aminoalkoxybibenzyl and its acid addition salt

Publications (1)

Publication Number Publication Date
ES474575A1 true ES474575A1 (es) 1980-01-16

Family

ID=27304972

Family Applications (2)

Application Number Title Priority Date Filing Date
ES474575A Expired ES474575A1 (es) 1977-10-07 1978-10-06 Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos
ES480091A Expired ES480091A1 (es) 1977-10-07 1979-04-30 Metodo de producir (omega-aminoalcoxi) bibencilos farmaceu- ticamente activos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES480091A Expired ES480091A1 (es) 1977-10-07 1979-04-30 Metodo de producir (omega-aminoalcoxi) bibencilos farmaceu- ticamente activos.

Country Status (13)

Country Link
US (2) US4220603A (es)
EP (1) EP0001759B1 (es)
CA (1) CA1105931A (es)
CS (1) CS209918B2 (es)
DD (1) DD139255A5 (es)
DE (1) DE2861477D1 (es)
DK (1) DK152040C (es)
ES (2) ES474575A1 (es)
FI (1) FI69840C (es)
HU (1) HU178306B (es)
IT (1) IT1099778B (es)
NO (1) NO146744C (es)
SU (1) SU786883A3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832847A (ja) * 1981-08-20 1983-02-25 Mitsubishi Chem Ind Ltd （３−アミノプロポキシ）ビベンジル類
JPH02304022A (ja) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp セロトニン拮抗剤
HUT70031A (en) * 1992-11-30 1995-09-28 Sankyo Co Alfa, omega-diarylalkane derivatives, their preparation and pharmaceutical compositions containing them
AU713236B2 (en) 1996-02-15 1999-11-25 Sankyo Company Limited Diarly alkane derivatives containing an alicyclic group, their preparation and their theraputic and prophylactic uses
KR101653816B1 (ko) 2014-06-25 2016-09-06 주식회사 대희화학 결정형 사포그릴레이트 옥살산염 일수화물 또는 이의 무수물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164607A (en) * 1961-01-10 1965-01-05 Upjohn Co 2-phenyl-3-(tertiary amino alkoxy) phenyl-indenes
US3077472A (en) * 1961-03-21 1963-02-12 Univ Kansas Res Foundation 3-[4-(aminoalkoxy)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
GB945864A (en) * 1961-08-18 1964-01-08 Richardson Merrell Inc Substituted triphenylethane
GB1063744A (en) * 1964-05-25 1967-03-30 American Cyanamid Co 4-substituted-4'-tertiary aminoalkoxy biphenyls
US3476767A (en) * 1965-10-11 1969-11-04 Ciba Geigy Corp 1,2-diaryl - 6 - tertiary amino lower-alkoxy-3,4-dihydro naphthalenes
BE754405A (fr) * 1969-08-05 1971-02-04 Thomae Gmbh Dr K Nouveaux beta-aryl-2-aminoalcoxystyrenes
US4024282A (en) * 1975-11-25 1977-05-17 Mitsubishi Chemical Industries Ltd. Pharmaceutically active 2-(3-alkylaminopropoxy)diphenylmethanes
JPS598265B2 (ja) * 1975-06-19 1984-02-23 三菱化学株式会社 オメガ − アミノアルコキシビフエニルルイ マタハ ソノサンフカエンノセイゾウホウ
NL188944C (nl) * 1975-06-19 1992-11-16 Mitsubishi Chem Ind Werkwijze voor het bereiden van omega-aminoalkoxybenzeenderivaten alsmede werkwijze voor het bereiden van farmaceutische preparaten met toepassing daarvan, als werkzame verbinding.
US4001216A (en) * 1975-10-30 1977-01-04 American Home Products Corporation Aminoalkyl ethers of 2,2'- and 3,3'-dihydroxydesoxybenzoin

Also Published As

Publication number Publication date
EP0001759A1 (en) 1979-05-16
FI69840B (fi) 1985-12-31
FI69840C (fi) 1986-05-26
US4220603A (en) 1980-09-02
DK152040C (da) 1988-07-11
IT1099778B (it) 1985-09-28
EP0001759B1 (en) 1981-12-30
ES480091A1 (es) 1980-04-01
IT7828531A0 (it) 1978-10-06
CS209918B2 (en) 1981-12-31
NO146744B (no) 1982-08-23
DD139255A5 (de) 1979-12-19
NO783399L (no) 1979-04-10
CA1105931A (en) 1981-07-28
HU178306B (en) 1982-04-28
DK152040B (da) 1988-01-25
FI783049A (fi) 1979-04-08
NO146744C (no) 1982-12-01
US4323568A (en) 1982-04-06
SU786883A3 (ru) 1980-12-07
DK441878A (da) 1979-04-08
DE2861477D1 (en) 1982-02-18

Similar Documents

Publication Publication Date Title
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
IL55387A (en) 1-(p-(beta-aminoalkoxy)phenyl)-1-p-hydroxyphenyl-2-phenyl alkene derivatives,process for their preparation and pharmaceutical compositions containing them
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
MY8700725A (en) O-substituted derivatives of (+)-cyanidan-3-ol, processes for their preparation and pharmaceutical compositions containing these compounds and their preparation
DE2860893D1 (en) Lipopeptides, process for their preparation and pharmaceutical compositions containing them
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES458123A1 (es) Un procedimiento para la preparacion de nuevos derivados de adenina.
HU174927B (hu) Sposob poluchenija proizvodnykh 1-benzazolilalkil-4-zamehhennykh-piperidinov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IL49422A (en) Substitutet 1-(w-triarylalkyl)-4-phenyl-4-piperidine-methanol derivatives, their preparation and pharmaceutical compositions containing them
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
IL49629A0 (en) New derivatives of 2-phenylamino-2-imidazoline,their preparation and pharmaceutical compositions containing them
ES8103969A1 (es) Un procedimiento para la preparacion de una solucion inyec- table estable de un quelato de oxitetraciclina
ES471809A1 (es) Procedimiento para preparar derivados de naftaleno
ES480091A1 (es) Metodo de producir (omega-aminoalcoxi) bibencilos farmaceu- ticamente activos.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
ES483662A1 (es) Un procedimiento para la produccion de una 2-aminoetil-1-fe-nilindolina
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
ES8203334A1 (es) Procedimiento para la obtencion de dehidropeptidos
ES466257A1 (es) Un procedimiento para la preparacion de nuevas aralquilani- linas sustituidas
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
DE2861177D1 (en) 2-benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them
HU174097B (hu) Sposob poluchenija proizvodnykh fenolefirov dvoe-zamehhennykh 3-amino-2-gidroksipropanom i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami